BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Folkert IW, Hernandez P, Roses RE. Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas. World J Gastroenterol 2016; 22(11): 3105-3116 [PMID: 27003988 DOI: 10.3748/wjg.v22.i11.3105]
URL: https://www.wjgnet.com/1007-9327/full/v22/i11/3105.htm
Number Citing Articles
1
Maurice Herring, Lynn Huynh, Mei Sheng Duh, Francis Vekeman, Audrey Tiew, Maureen Neary, Emily Bergsland. Real-world treatment patterns in advanced pancreatic neuroendocrine tumors in the era of targeted therapy: perspectives from an academic tertiary center and community oncology practicesMedical Oncology 2017; 34(5) doi: 10.1007/s12032-017-0927-0
2
Dionysia Kelgiorgi, Christos Dervenis. Pancreatic neuroendocrine tumors: the basics, the gray zone, and the targetF1000Research 2017; 6: 663 doi: 10.12688/f1000research.10188.1
3
Eunsung Jun, Song Cheol Kim, Ki Byung Song, Dae Wook Hwang, Jae Hoon Lee, Sang Hyun Shin, Seung Mo Hong, Kwang-Min Park, Young-Joo Lee. Diagnostic value of chromogranin A in pancreatic neuroendocrine tumors depends on tumor size: A prospective observational study from a single instituteSurgery 2017; 162(1): 120 doi: 10.1016/j.surg.2017.01.019
4
Mohammad Y. Zaidi, Alexandra G. Lopez-Aguiar, Jeffrey M. Switchenko, Joseph Lipscomb, Valentina Andreasi, Stefano Partelli, Adriana C. Gamboa, Rachel M. Lee, George A. Poultsides, Mary Dillhoff, Flavio G. Rocha, Kamran Idrees, Clifford S. Cho, Sharon M. Weber, Ryan C. Fields, Charles A. Staley, Massimo Falconi, Shishir K. Maithel. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine TumorsAnnals of Surgery 2019; 270(3): 422 doi: 10.1097/SLA.0000000000003461
5
Yulong Li, William F Simonds. Recent advances in the management of endocrine malignancies associated with hereditary hyperparathyroidism syndromesInternational Journal of Endocrine Oncology 2017; 4(2): 85 doi: 10.2217/ije-2016-0018